Biomarker-guided withdrawal of inhaled corticosteroids in asthma patients with a non-T2 inflammatory phenotype – a randomized controlled trial study protocol

BACKGROUND: Non-T2 asthma is characterized by the absence of elevated type 2 inflammatory biomarkers such as blood-eosinophils, total and allergen-specific Immunoglobulin E and Fractional exhaled Nitric Oxide (FeNO). According to guidelines, inhaled corticosteroids (ICS) are the cornerstone of asthm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosbech, Christiane Hammershaimb, Godtfredsen, Nina Skavlan, Ulrik, Charlotte Suppli, Westergaard, Christian Grabow
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552380/
https://www.ncbi.nlm.nih.gov/pubmed/37794472
http://dx.doi.org/10.1186/s12890-023-02679-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552380/
https://www.ncbi.nlm.nih.gov/pubmed/37794472
http://dx.doi.org/10.1186/s12890-023-02679-y

Ejemplares similares